Literature DB >> 21391058

The need for ibogaine in drug and alcohol addiction treatment.

Jennifer R Donnelly1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21391058     DOI： 10.1080/01947648.2011.550832

Source DB:  PubMed          Journal:  J Leg Med        ISSN： 0194-7648


× No keyword cloud information.
  4 in total

1.  An Ethical Exploration of Barriers to Research on Controlled Drugs.

Authors:  Michael H Andreae; Evelyn Rhodes; Tyler Bourgoise; George M Carter; Robert S White; Debbie Indyk; Henry Sacks; Rosamond Rhodes
Journal:  Am J Bioeth       Date:  2016       Impact factor: 11.229

2.  The mechanistic basis for noncompetitive ibogaine inhibition of serotonin and dopamine transporters.

Authors:  Simon Bulling; Klaus Schicker; Yuan-Wei Zhang; Thomas Steinkellner; Thomas Stockner; Christian W Gruber; Stefan Boehm; Michael Freissmuth; Gary Rudnick; Harald H Sitte; Walter Sandtner
Journal:  J Biol Chem       Date:  2012-03-26       Impact factor: 5.486

3.  The Effects of Ibogaine on Uterine Smooth Muscle Contractions: Relation to the Activity of Antioxidant Enzymes.

Authors:  Zorana Oreščanin-Dušić; Nikola Tatalović; Teodora Vidonja-Uzelac; Jelena Nestorov; Aleksandra Nikolić-Kokić; Ana Mijušković; Mihajlo Spasić; Roman Paškulin; Mara Bresjanac; Duško Blagojević
Journal:  Oxid Med Cell Longev       Date:  2018-02-11       Impact factor: 6.543

4.  Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile.

Authors:  Xaver Koenig; Michael Kovar; Lena Rubi; Agnes K Mike; Peter Lukacs; Vaibhavkumar S Gawali; Hannes Todt; Karlheinz Hilber; Walter Sandtner
Journal:  Toxicol Appl Pharmacol       Date:  2013-05-22       Impact factor: 4.219
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.